CVS Pharmacy, Inc. Secures Settlement for Fraudulent Medicaid Billing — $36.5 Million
RedMap Risk Score
80/100
CRITICAL RISK
Risk Signal Summary
New York Attorney General Letitia James, along with 36 other AGs, secured a $36.5 million settlement from CVS for overbilling Medicaid for insulin prescriptions from 2010 to 2020. CVS dispensed excess insulin while falsely reporting amounts, leading to significant overpayments.
Why This Matters
Governance and compliance anomalies in organizations managing public funds or charitable assets directly affect donors, beneficiaries, and taxpayers. The risk indicators identified in this report warrant further scrutiny by regulators, donors, and oversight bodies.
Create a free account
Unlimited access to all articles · No daily limit
No credit card · Instant access
Multiple related entities detected
🔒 Cvs Pharmacy, Inc. has potential risk indicators with connected organizations. Unlock full network analysis.
Sign up free to unlock →Disclaimer: This report identifies risk indicators and unusual financial patterns based on publicly available IRS Form 990 data and government enforcement records. It does not assert fraud, criminal conduct, or legal violations. All findings are for informational purposes only and should not be construed as legal or financial advice.
Share this finding
You just analyzed Cvs Pharmacy, Inc. — Risk Score 80/100, $36.5M involved. Share this with your network.
Post text is pre-formatted for maximum reach — you can edit before posting.
Discover more risk signals across the USA.